FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
The storm of flu, pneumonia, colds and other germs circulating this winter drove a massive surge in the number of Australians taking sick leave.
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before ...
(Reuters) -The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...
Pneumococcal bacteria are present in the normal microbiome of the nose of many children and adults. In certain circumstances, ...
Pneumococcal vaccination may reduce the risk for pneumonia-related morbidity and mortality among patients with immune-mediated inflammatory diseases.
Discover the significant differences in influenza and COVID-19 vaccination rates among children receiving long-term ...
A growing number of U.S. adults are hesitant to get recommended vaccines this fall, a new survey found. Doctors discuss ...